Darzalex 100 mg (Daratumumab SOLUTION) 100 MG

DARZALEX 100 MG is a solution for intravenous use, containing the active ingredient daratumumab. This medication is commonly used in the management of certain hematologic conditions. It is manufactured by Janssen Inc. in Canada.

Strength

100 MG

Pack Size

5ML

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

DARZALEX 100 MG is primarily used in the treatment of specific types of blood cancers. Daratumumab, the active ingredient, is a monoclonal antibody that targets certain proteins on the surface of cancer cells. This medication is often prescribed as part of a comprehensive treatment plan for conditions like multiple myeloma. Patients should consult their healthcare provider to understand what is DARZALEX used for in their specific case.

Side Effects

Common effects of DARZALEX 100 MG may include infusion-related reactions, such as fever, chills, and shortness of breath. Other potential effects include fatigue, nausea, and upper respiratory tract infections. These effects can vary from person to person, and not everyone will experience them. It is important to discuss any concerns with a healthcare professional.

Precautions & Warnings

DARZALEX 100 MG should be handled with care and administered by a healthcare professional. It is crucial to follow the prescribed dosage and administration instructions. Patients with a history of severe allergic reactions or certain medical conditions should inform their healthcare provider before starting this medication. Proper storage and handling are essential to maintain the integrity of the solution.

Avoid Interactions

DARZALEX 100 MG may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with this medication, so it is advisable to discuss any dietary restrictions with your healthcare provider.

References

Frequently Asked Questions

DARZALEX 100 MG is used in the treatment of certain types of blood cancers, often as part of a comprehensive treatment plan.

DARZALEX 100 MG is administered intravenously by a healthcare professional.

Common side effects may include infusion-related reactions, fatigue, nausea, and upper respiratory tract infections.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Patients should follow the prescribed dosage and administration instructions and inform their healthcare provider about any severe allergic reactions or medical conditions.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.